Price $59.59 |
Market Cap
3.45B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
43.0
|
P/B
4.63
|
P/S
3.89
|
Dividend %
-
|
|
P/CF
61.8
|
P/FCF
47.7
|
Op. Cash Flow
108.8K
|
FCF
1.4
|
|
Op. Margin
10.30%
|
Net Margin
9.10%
|
ROE
11.70%
|
ROI
6.70%
|
|
ROA
5.30%
|
EPS Growth
3.70%
|
Current Ratio
2.7
|
Debt/Equity
94.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Genesis Healthcare Inc (GENN) | $0.25 | - | - | 53.6M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $68.73 | - | 2.90% | 148.62B | Strong Buy |
| IntriCon Corporation (IIN) | $23.80 | - | - | 200M | Strong Buy |
| Predictive Technology Group In (PRED) | $0.21 | - | - | 131.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
